Cite
TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy.
MLA
Xu, Dengqiu, et al. “TAK1 Inhibition Improves Myoblast Differentiation and Alleviates Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy.” Journal of Cachexia, Sarcopenia & Muscle, vol. 12, no. 1, Feb. 2021, pp. 192–208. EBSCOhost, https://doi.org/10.1002/jcsm.12650.
APA
Xu, D., Li, S., Wang, L., Jiang, J., Zhao, L., Huang, X., Sun, Z., Li, C., Sun, L., Li, X., Jiang, Z., & Zhang, L. (2021). TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy. Journal of Cachexia, Sarcopenia & Muscle, 12(1), 192–208. https://doi.org/10.1002/jcsm.12650
Chicago
Xu, Dengqiu, Sijia Li, Lu Wang, Jingwei Jiang, Lei Zhao, Xiaofei Huang, Zeren Sun, et al. 2021. “TAK1 Inhibition Improves Myoblast Differentiation and Alleviates Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy.” Journal of Cachexia, Sarcopenia & Muscle 12 (1): 192–208. doi:10.1002/jcsm.12650.